The next step would be to add other related mutations to evaluate the possibility of multiplexing our quantitative assay as other mutations in either exon 12, 13 and 15 of JAK2 [27,28] or other genes [26] linked to MPN have recently been reported. The gene discussed is JAK2; the disease is myeloproliferative neoplasm.